CELLECTA, INC.
Doing business as CELLECTA INC
- MOUNTAIN VIEW, CA 94043-4040
- cellecta.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $57.2K
- Awards on record
- 4
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
CELLECTA, INC. has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About CELLECTA, INC.
- Headquarters
- MOUNTAIN VIEW, CA 94043-4040
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIENT1Z37DAHJ8
- CAGE4GCV9
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
- 36-month obligations
- $57.2K
- Awards on record
- 4
- Top funding agencies
- National Institutes of Health
Awards
75N98026P00481
Recompete < 6 mo: Potential end May 10, 2027 (5 months away)NCATS: SERVICE: CUSTOM KNOCK-IN CELL LINES: NON-SEVERABLE
Department of Health and Human Services · National Institutes of Health
- Obligated
- $19.2K
- Period of performance
- May 11, 2026 – May 10, 2027
75N95C25P00085
Completed: Period of performance ended Jul 21, 2026CUSTOM POOLED CRISPR KO LIBRARY
Department of Health and Human Services · National Institutes of Health
- Obligated
- $14K
- Period of performance
- Jul 22, 2025 – Jul 21, 2026
HU000124P0004
Completed: Period of performance ended Nov 12, 2024COMPREHENSIVE CRISPR-CAS9 KNOCKOUT (KO) SCREENING TO DETERMINE GROWTH SUPPRESSOR MUTATIONS IN MOUSE EMBRYONIC STEM CELLS.
Department of Defense · Uniformed Services University of the Health Sciences
- Obligated
- $0
- Period of performance
- Nov 13, 2023 – Nov 12, 2024
75N95024P00336
Completed: Period of performance ended Sep 18, 2024CELLECTA, INCORPORATED:1145260 [24-004505]
Department of Health and Human Services · National Institutes of Health
- Obligated
- $24K
- Period of performance
- Jun 18, 2024 – Sep 18, 2024
| Award | Agency | NAICS · PSC | Obligated | Period of performance | Recompete |
|---|---|---|---|---|---|
75N98026P00481 NCATS: SERVICE: CUSTOM KNOCK-IN CELL LINES: NON-SEVERABLE | Department of Health and Human Services · National Institutes of Health | 541714 · 6505DRUGS AND BIOLOGICALS | $19.2K | May 11, 2026 – May 10, 2027 | Recompete < 6 mo: Potential end May 10, 2027 (5 months away)AI brief for award 75N98026P00481Bid team for the recompete of award 75N98026P00481 |
75N95C25P00085 CUSTOM POOLED CRISPR KO LIBRARY | Department of Health and Human Services · National Institutes of Health | 541990 · 6505DRUGS AND BIOLOGICALS | $14K | Jul 22, 2025 – Jul 21, 2026 | Completed: Period of performance ended Jul 21, 2026 |
HU000124P0004 COMPREHENSIVE CRISPR-CAS9 KNOCKOUT (KO) SCREENING TO DETERMINE GROWTH SUPPRESSOR MUTATIONS IN MOUSE EMBRYONIC STEM CELLS. | Department of Defense · Uniformed Services University of the Health Sciences | 541714 · AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH | $0 | Nov 13, 2023 – Nov 12, 2024 | Completed: Period of performance ended Nov 12, 2024 |
75N95024P00336 CELLECTA, INCORPORATED:1145260 [24-004505] | Department of Health and Human Services · National Institutes of Health | 541380 · Q301REFERENCE LABORATORY TESTING | $24K | Jun 18, 2024 – Sep 18, 2024 | Completed: Period of performance ended Sep 18, 2024 |
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 16 awards
- Total awarded
- $9,998,507
- By phase
- SBIR Phase I: 11
- SBIR Phase II: 5
- By agency
- Department of Health and Human Services: 16
- Active projects
- 0 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2017: 1
- 2015: 1
- 2013: 1
- 2012: 1
- 2011: 1
- 2010: 3
- 2009: 3
- 2008: 2
- 2007: 3
Awards (most recent first)
CRISPR Genome-Wide sgRNA Library Screening Platform
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2017 · $1,496,262
Dec 19, 2016 – Nov 30, 2018
Solicitation PA15-269 (2015) · Topic 172
Open Resource CRISPR/CAS9 Genome-Wide sgRNA Library Screening Platform
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $224,905
Jun 1, 2015 – Nov 30, 2015
Solicitation PA14-071 (2015) · Topic 172
TOPIC 316 PHASE I: GENETIC ANALYSIS OF CTCS AT THE SINGLE CELL LEVEL; HHSN261201
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2013 · $299,952
Solicitation year 2013 · Topic NCI · Research partner: Stub
IGF::OT::IGF SBIR PHASE II TOPIC 290 RNAI SYNTHETIC LETHAL SCREEN IN CANCER CELL MODELS.
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $999,596
Solicitation year 2012 · Topic NCI · Research partner: Stub
Exploiting synthetic lethality of hematopoietic lineage cells to develop novel ta
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2011 · $1,865,575
Solicitation PA10-050 (2011) · Topic NCI · Research partner: Stub
Isolation of Peptide Radioprotectors
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $600,000
Solicitation PHS2010-2 (2010) · Topic NCI
Functionally Validated Lentiviral siRNA libraries
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2010 · $1,860,300
Solicitation PHS2010-2 (2010) · Topic NCRR
Not Available
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2010 · $199,681
Solicitation PHS2010-1 (2010) · Topic NCI
Identification of Hematopoietic Stem and Progenitor Cell Viability Genes
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $249,465
Solicitation PHS2009-2 (2009)
Drug Targets of Heat Shock Response
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $237,368
Solicitation PHS2009-2 (2009)
Inhibitors of Heat Shock Response
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2009 · $234,168
Solicitation PHS2009-2 (2009)
Array-assisted Insertional Mutagenesis Platform for Forward Genetics of Cancer
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $187,669
Solicitation PHS2007-2 (2008)
Viability Pathway Models in Prostate Cancer Cells
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $298,073
Solicitation PHS2007-2 (2008)
Functionally Validated Lentiviral siRNA Libraries
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $289,398
Solicitation year 2007
High Throughput Screening of Peptide Pharmaceuticals
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $252,345
Solicitation year 2007
Algorithm and genome-wide database of functional siRNAs
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2007 · $703,750
Solicitation year 2007
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)Primary
SAM.gov does not report this entity as small under any listed NAICS code.
Socio-economic status
No socio-economic certifications reported in SAM.gov.
Product & service codes (PSC)
- AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with CELLECTA, INC.?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.
